Purpose Beyond a Cure: Advancing Hodgkin Lymphoma Treatment (UF Health)

Purpose Beyond a Cure: Advancing Hodgkin Lymphoma Treatment

Emilie Lynch has passed the five-year milestone that doctors consider a yardstick for being cured of Hodgkin lymphoma not once but three times. She’s channeling her experience into a career as a clinical pharmacy specialist at UF Health, where she works to improve treatment for young people with the same blood cancer she had at 16.

Hodgkin lymphoma, a cancer that affects the lymphatic system and limits the body’s ability to fight infections, has survival rates close to 90% for children and young adults. Treatments are advancing quickly. Yet, the threat of long-term adverse effects from standard chemotherapy and radiation treatment is ever-present for patients like Emilie.

Read more about Purpose Beyond a Cure: Advancing Hodgkin Lymphoma Treatment.